Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies with Early Access Authorization in Immunocompromised Patients. a Prospective Cohort.

CompletedOBSERVATIONAL

Enrollment

149

Participants

Timeline

Start Date

January 26, 2022

Primary Completion Date

November 3, 2023

Study Completion Date

October 31, 2024

Conditions

COVID-19Immunocompromised Host

Trial Locations (1)

Hôpital Avicenne, Bobigny

All Listed Sponsors

lead

ANRS, Emerging Infectious Diseases

OTHER_GOV